Scribe Therapeutics Inc SCTX

US Biotechnology

$21.28 ▼ -1.53% ($-0.33)

🎈 Low Float

Open $23.17

Prev Close $21.61

Day Range $20.21 – $23.28

52W Range $17.31 – $39.60

Market Cap $402.87M

Beta -1.90

📋 Company Profile

Industry	Biotechnology
Country	US
Exchange	NASDAQ NMS - GLOBAL MARKET
IPO Date	2026-07-24
Shares Out.	17,580,000
Website	scribetx.com ↗
Phone	19086427374

About Scribe Therapeutics Inc

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.

Scribe Therapeutics Inc is a publicly traded company under the ticker symbol SCTX on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.